Pfizer in talks on $5 billion acquisition: media

Pfizer in talks on $5 billion acquisition: media

A man walks past the Pfizer logo on the drug maker’s headquarters in New York. American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported. Pfizer, one of the top makers of COVID-19 vaccines